CLINICAL OUTCOMES OF POSTERIOR FOSSA TUMOR SURGERY WITHOUT PREOPERATIVE VENTRICULAR-PERITONEAL SHUNT
Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2018, Vol 5, Issue 7
Abstract
The aim of the study was to assess the clinical outcome of surgically treated patients with posterior fossa tumor with hydrocephalus with symptoms and signs of raised intracranial pressure without pre-operative ventriculo-peritoneal shunt by comparing two groups (one group-with pre-operative ventriculo-peritoneal shunt and other group-without preoperative ventriculo-peritoneal shunt) in respect to complications, duration of hospital stay and final outcome at 1 month post-operative follow up. This clinical study was carried out at the department of neurosurgery, BSMMU from November 2008 to April 2010 on patients with posterior fossa tumor with hydrocephalus with symptoms and signs of raised intracranial pressure (ICP) who underwent surgery without preoperative ventriculo-peritoneal shunt. A total of 32 patients were included in this study. Patients were divided into two groups, control group (group-A) underwent ventriculo peritoneal shunt prior to tumor surgery and experimental group (group-B) were not treated with ventriculo-peritoneal shunt prior to tumor surgery. Both groups were followed up during hospital stay and after 1 month of tumor resection. Clinical studies include analysis of the following parameters: i) duration of hospital stay, ii) post-operative complications include cerebrospinal fluid leakage, pseudomeningocele, seizure, meningitis, and shunt blockage and, iii) final outcome at 1 month follow up in modified karnofsky performance scale. We also observed whether or not, use of ventriculo-peritoneal shunt to drain cerebrospinal fluid was useful and safe. The mean duration of hospital stay were 95.1±12.6 days with ranged from 70 to 120 days and 71.5±12.6 days ranged from 36 to 88 days in group-A and group-B respectively. The majority of the patients had no complications in both group, which were 12(70.6%) and 9 (60.0%) in group A and group B respectively. Final outcome at 1 month follow up in modified karnofsky performance scale in both groups were similar.
Authors and Affiliations
Rafiqul Islam
Keywords
Related Articles
- EP ID EP636191
- DOI -
- Views 141
- Downloads 0
DEVELOPMENT OF HENOCH-SCHONLEIN PURPURA NEPHRITIS AND MIGRATORY POLYARTHRITIS IN A PATIENT WITH IG A NEPHROPATHY
Henoch-Schonlein purpura is a type of systemic vasculitis characterized by deposition of IgA on the vascular wall. Skin, joints, kidney, gastrointestinal tract and other organs may be affected. In this paper we present a...
AMALAKI (EMBLICA OFFICINALIS GEARTN): AN OVERVIEW ON THERAPEUTIC USES WITH SPECIAL REFERANCE TO BRIHATTRAYI
Ayurveda- the earliest system of health sciences believes in the intimate relationship of man and nature. Post Vedic Period is the period when Ayurveda emerged in its crystalline form as a result of discussion and seriou...
EVALUATION OF PLASMA HOMOCYSTEINE LEVEL IN DIABETES MELLITUS PATIENTS IN KHARTOUM STATE
Background: Diabetes mellitus (DM) Is metabolic disorder characterized by chronic hyper glycemia with disturbance in carbohydrate, fat and protein metabolism arising from defect in insulin secretion, action or both.[1] T...
POLYMORPHISM IN THE GLUTHATHIONE S-TRANSFERASE THETA AND MU GENES AND SUSCEPTIBILITY TO LYMPHOID LEUKEMIA IN SUDANESE PATIENTS
Background: Glutathione S-transferase (GST) are a family of cytosolic enzymes known to catalyze the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins, and products...
FORMULATION SPAN 40 NIOSOME OF AQUEOUS FRACTION MENIRAN (PHYLLANTHUS NIRURI L.)
Meniran (Phyllanthus niruri L.) is used for many conditions such as diabetes mellitus, hypertension, obesity and hyperlipidemia. The active constituens to which the antidiabetic activity of P. niruri L. has been attribut...